Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUTO trial in treated HIV-1 infection
2026-525211-14-00Phase 2Authorised
- Sponsor
- Erasmus MC
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pyrimethamine, lenalidomide and topiramate in Human immunodeficiency virus infection type 1 (4 arms), sponsored by Erasmus MC. Planned start Jul 2026; status: authorised.
02
Drugs
pyrimethaminelenalidomidetopiramate
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2026-525211-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525211-14-00.